308 related articles for article (PubMed ID: 28737257)
21. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.
Kluwe L; Mautner V; Heinrich B; Dezube R; Jacoby LB; Friedrich RE; MacCollin M
J Med Genet; 2003 Feb; 40(2):109-14. PubMed ID: 12566519
[TBL] [Abstract][Full Text] [Related]
22. Targeted deep sequencing of DNA from multiple tissue types improves the diagnostic rate and reveals a highly diverse phenotype of mosaic neurofibromatosis type 2.
Teranishi Y; Miyawaki S; Hongo H; Dofuku S; Okano A; Takayanagi S; Ota T; Yoshimura J; Qu W; Mitsui J; Nakatomi H; Morishita S; Tsuji S; Saito N
J Med Genet; 2021 Oct; 58(10):701-711. PubMed ID: 33067351
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
Abedalthagafi M; Bi WL; Aizer AA; Merrill PH; Brewster R; Agarwalla PK; Listewnik ML; Dias-Santagata D; Thorner AR; Van Hummelen P; Brastianos PK; Reardon DA; Wen PY; Al-Mefty O; Ramkissoon SH; Folkerth RD; Ligon KL; Ligon AH; Alexander BM; Dunn IF; Beroukhim R; Santagata S
Neuro Oncol; 2016 May; 18(5):649-55. PubMed ID: 26826201
[TBL] [Abstract][Full Text] [Related]
24. NF2 mutations in secretory and other rare variants of meningiomas.
Hartmann C; Sieberns J; Gehlhaar C; Simon M; Paulus W; von Deimling A
Brain Pathol; 2006 Jan; 16(1):15-9. PubMed ID: 16612978
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
26. Infratentorial meningioma in an 8-year-old child as first sign of neurofibromatosis type 2.
Stettner GM; Rostasy KM; Ludwig HC; Merkler D; Fahsold R; Gärtner J
Neuropediatrics; 2007 Feb; 38(1):29-31. PubMed ID: 17607601
[TBL] [Abstract][Full Text] [Related]
27. SWI/SNF chromatin remodeling complex alterations in meningioma.
Gill CM; Loewenstern J; Rutland JW; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Fowkes M; Shrivastava RK
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3431-3440. PubMed ID: 33715086
[TBL] [Abstract][Full Text] [Related]
28. Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas.
Lomas J; Bello MJ; Alonso ME; Gonzalez-Gomez P; Arjona D; Kusak ME; de Campos JM; Sarasa JL; Rey JA
Hum Pathol; 2002 Mar; 33(3):375-8. PubMed ID: 11979381
[TBL] [Abstract][Full Text] [Related]
29. Cases of Mixed Schwannoma-Meningioma With and Without Neurofibromatosis 2 with Emphasis on Tumorigenesis.
Rajeswarie RT; Mallik D; Rudrappa S; Gopal S
Int J Surg Pathol; 2024 May; 32(3):511-514. PubMed ID: 37487199
[TBL] [Abstract][Full Text] [Related]
30. A patient with mosaic neurofibromatosis type 2 presenting with early onset meningioma.
Chu YW; Cheuk DK; Chung BH; Bowers NL; Ha SY; Chiang AK; Chan GC
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25406210
[TBL] [Abstract][Full Text] [Related]
31. The neurofibromatoses. Part 2: NF2 and schwannomatosis.
Lu-Emerson C; Plotkin SR
Rev Neurol Dis; 2009; 6(3):E81-6. PubMed ID: 19898272
[TBL] [Abstract][Full Text] [Related]
32. Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.
Baser ME; Makariou EV; Parry DM
J Neurosurg; 2002 Feb; 96(2):217-22. PubMed ID: 11838793
[TBL] [Abstract][Full Text] [Related]
33. Genetic landscape of meningioma.
Yuzawa S; Nishihara H; Tanaka S
Brain Tumor Pathol; 2016 Oct; 33(4):237-247. PubMed ID: 27624470
[TBL] [Abstract][Full Text] [Related]
34. What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?
Evans DG; Ramsden RT; Shenton A; Gokhale C; Bowers N; Huson SM; Wallace AJ
J Neurosurg; 2008 Jan; 108(1):92-6. PubMed ID: 18173316
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a severe case of PIK3CA-related overgrowth at autopsy by droplet digital polymerase chain reaction and report of PIK3CA sequencing in 22 patients.
Piacitelli AM; Jensen DM; Brandling-Bennett H; Gray MM; Batra M; Gust J; Thaker A; Paschal C; Tsuchiya K; Pritchard CC; Perkins J; Mirzaa GM; Bennett JT
Am J Med Genet A; 2018 Nov; 176(11):2301-2308. PubMed ID: 30063105
[TBL] [Abstract][Full Text] [Related]
36. Respective roles of Pik3ca mutations and cyproterone acetate impregnation in mouse meningioma tumorigenesis.
Cômes PC; Le Van T; Tran S; Huard S; Abi-Jaoude S; Venot Q; Marijon P; Boetto J; Blouin A; Bielle F; Ducos Y; Teranishi Y; Kalamarides M; Peyre M
Cancer Gene Ther; 2023 Aug; 30(8):1114-1123. PubMed ID: 37188724
[TBL] [Abstract][Full Text] [Related]
37. A role for the p53 pathway in the pathology of meningiomas with NF2 loss.
Chang Z; Guo CL; Ahronowitz I; Stemmer-Rachamimov AO; MacCollin M; Nunes FP
J Neurooncol; 2009 Feb; 91(3):265-70. PubMed ID: 18974932
[TBL] [Abstract][Full Text] [Related]
38. Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas.
Dewan R; Pemov A; Kim HJ; Morgan KL; Vasquez RA; Chittiboina P; Wang X; Chandrasekharappa SC; Ray-Chaudhury A; Butman JA; Stewart DR; Asthagiri AR
Neuro Oncol; 2015 Apr; 17(4):566-73. PubMed ID: 25452392
[TBL] [Abstract][Full Text] [Related]
39. Neurofibromatosis type 2.
Slattery WH
Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141
[TBL] [Abstract][Full Text] [Related]
40. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A
Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
